Creative Capital Management Investments LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1957363
SAN DIEGO, CA
Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$505,739
-$40,033 QoQ
Shares Held
4,003
+2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#1,362
of 2,266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Creative Capital Management Investments LLC holds $2,330,399 across 12 Drug Manufacturers - General names. GILD ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
520 | $623,703 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
4,003 | $505,739 | |
| 3 | ABBV |
AbbVie Inc.
|
1,492 | $375,446 | |
| 4 | AMGN |
Amgen Inc
|
645 | $233,567 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
3,255 | $187,553 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,287 | $165,379 | |
| 7 | PFE |
Pfizer Inc
|
5,911 | $142,336 | |
| 8 | JNJ |
Johnson & Johnson
|
311 | $78,984 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $505,739 | 4,003 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $545,772 | 3,916 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $480,649 | 3,916 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $433,344 | 3,904 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $432,836 | 3,904 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $443,493 | 3,958 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $365,600 | 3,958 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $298,889 | 3,565 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||